• LAST PRICE
    19.9800
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.0000/ 0
  • Ask / Lots
    28.5000/ 1
  • Open / Previous Close
    0.0000 / 19.9800
  • Day Range
    ---
  • 52 Week Range
    Low 13.0500
    High 30.8900
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 20.47
TimeVolumeREPL
09:32 ET132520.47
09:35 ET21020.72
09:39 ET21220.335
09:42 ET10020.165
09:50 ET10020.165
09:53 ET65220.3288
09:55 ET1525020.37
10:02 ET10020.165
10:04 ET10020.28
10:06 ET100920.18
10:08 ET40020.185
10:09 ET20020.47
10:15 ET10020.49
10:18 ET80020.49
10:20 ET10020.48
10:22 ET20020.4
10:24 ET10020.47
10:26 ET20020.455
10:27 ET178920.31
10:29 ET10020.35
10:31 ET50020.3611
10:33 ET10020.28
10:36 ET20020.19
10:38 ET50020.27
10:40 ET30020.23
10:42 ET30020.29
10:45 ET20020.36
10:47 ET60020.2475
10:51 ET90020.295
10:54 ET30020.31
10:56 ET40020.3
10:58 ET10020.38
11:00 ET20020.525
11:03 ET10020.66
11:05 ET10020.66
11:07 ET30020.56
11:09 ET10020.66
11:12 ET10020.66
11:14 ET10020.66
11:16 ET20020.62
11:18 ET10020.61
11:20 ET10020.61
11:21 ET70020.83
11:23 ET20020.83
11:25 ET10020.83
11:27 ET10020.83
11:30 ET30120.81
11:32 ET20020.78
11:34 ET10020.78
11:36 ET20020.7
11:38 ET80020.78
11:39 ET10020.78
11:41 ET30020.72
11:43 ET10020.71
11:45 ET20020.71
11:48 ET30020.635
11:50 ET30020.65
11:52 ET10020.71
11:54 ET30020.71
11:56 ET10020.71
11:57 ET10020.71
11:59 ET60020.71
12:06 ET148120.6
12:08 ET10020.58
12:10 ET10020.6
12:12 ET30020.56
12:15 ET10020.56
12:19 ET10020.45
12:21 ET10020.475
12:24 ET10020.4
12:32 ET10020.34
12:33 ET10020.44
12:37 ET10020.405
12:42 ET80020.34
12:48 ET10020.33
12:50 ET10020.3
12:51 ET10020.19
12:53 ET554020.26
12:55 ET10020.32
01:00 ET30020.32
01:02 ET60520.33
01:08 ET20120.42
01:18 ET10020.46
01:20 ET50020.38
01:24 ET20020.44
01:33 ET10020.48
01:38 ET10020.51
01:40 ET10020.45
01:44 ET60020.5
01:45 ET10020.46
01:49 ET50020.45
01:54 ET10020.44
01:56 ET10020.41
01:58 ET20020.28
02:00 ET10020.33
02:02 ET51020.31
02:03 ET10020.36
02:05 ET10020.41
02:09 ET50020.325
02:12 ET30020.37
02:16 ET10020.47
02:18 ET40020.41
02:20 ET50020.425
02:21 ET10020.39
02:23 ET10020.47
02:25 ET10020.47
02:27 ET20020.37
02:30 ET30020.405
02:32 ET50220.34
02:34 ET10020.325
02:36 ET20020.37
02:39 ET10020.37
02:43 ET10020.37
02:45 ET10020.37
02:48 ET10020.28
02:50 ET10020.37
02:52 ET30020.37
02:54 ET20020.325
02:56 ET20020.315
02:59 ET207320.28
03:01 ET80020.18
03:03 ET10020.17
03:06 ET120020.23
03:08 ET10020.33
03:10 ET20020.27
03:12 ET10020.34
03:14 ET10020.34
03:17 ET20020.335
03:19 ET10020.285
03:21 ET20020.23
03:24 ET10020.34
03:26 ET120020.18
03:28 ET32720.13
03:30 ET50020.13
03:32 ET144820.24
03:33 ET10020.29
03:35 ET20020.24
03:37 ET20020.245
03:39 ET26720.14
03:42 ET10020.155
03:44 ET60020.155
03:46 ET40020.165
03:48 ET141020.08
03:50 ET10020.085
03:51 ET666119.91
03:53 ET378019.825
03:55 ET432319.9
03:57 ET517920.04
04:00 ET551219.98
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesREPL
Replimune Group Inc
993.8M
-7.3x
---
United StatesIOVA
Iovance Biotherapeutics Inc
1.0B
-2.6x
---
United StatesARQT
Arcutis Biotherapeutics Inc
1.0B
-2.9x
---
United StatesLYEL
Lyell Immunopharma Inc
1.0B
-3.9x
---
United StatesCRNX
Crinetics Pharmaceuticals Inc
945.5M
-5.9x
---
United StatesVRDN
Viridian Therapeutics Inc
1.0B
-6.2x
---
As of 2022-12-02

Company Information

Replimune Group, Inc. is a clinical-stage biotechnology company engaged in the business of oncolytic immunotherapy to treat the cancer patients. The Company is advancing a pipeline of tumor-directed oncolytic immunotherapies derived from its RPx platform to fill unmet need across cancer types. The Company's lead product candidate, RP1, is a selectively replicating version of HSV-1 that expresses GALV-GP R and human GM-CSF. RP1 is designed to treat more immune responsive tumor types. The Company's pipeline product candidates include RP2 and RP3. The encoded GALV-GP R protein enhances the tumor killing ability of the virus and increases immunogenic cell death. RP2 is an additionally encodes an anti-CTLA-4 antibody has designed to treat more immunologically silent tumors. RP3 expresses a pair of immune costimulatory pathway activating ligands, CD40L and 4-1BBL, to further increase the potency of the immune responses to treat immunologically cold tumors.

Contact Information

Headquarters
500 Unicorn Park DrWOBURN, MA, United States 01801-3377
Phone
781-222-9600
Fax
302-655-5049

Executives

Independent Non-Executive Chairman of the Board
Dieter Weinand
President, Director, Chief Research & Development Officer
Robert Coffin
Chief Executive Officer, Director
Philip Astley-Sparke
Chief Financial Officer, Treasurer
Jean Franchi
Chief Operating Officer
Colin Love

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$993.8M
Revenue (TTM)
$0.00
Shares Outstanding
49.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.86
EPS
$-2.74
Book Value
$8.69
P/E Ratio
-7.3x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.